Health ❯ Healthcare ❯ Medications

GLP-1 Receptor Agonists

Semaglutide Anti-Cancer Effects Peripheral Artery Disease Asthma Treatment Wegovy and Ozempic Retatrutide Breast Cancer Prevention Foundayo Effects on Health Orforglipron Mounjaro and Wegovy Alzheimer's Disease Ozempic, Wegovy, Rybelsus, Mounjaro Eligibility and Access Wegovy and Mounjaro Ozempic Liraglutide Pregnancy Outcomes Long-term Effects Eligibility Criteria Wegovy Clinical Benefits Benefits and Risks Tirzepatide

Oral Semaglutide Linked to Fewer Heavy Drinking Days in Small Randomized Trial

The result points to oral semaglutide as a potential harm‑reduction option pending larger trials and regulatory review.

Study Finds GLP‑1 Diabetes Drugs Linked to Fewer Deaths and Limb Procedures in People With PAD

Penn Study Finds About 30% Lower Breast Cancer Rates Associated With GLP‑1 Use

17 Million U.S. Youth Eligible for GLP-1 Therapies Face Coverage and Care Barriers